医疗管理与结肠切除率的变化:1963-2010年瑞典厄勒布鲁溃疡性结肠炎流行病学与自然病程的基于人群队列研究
该研究基于瑞典厄勒布鲁大学医院结肠炎门诊档案中的全部病历,比较1963-1975、1976-1990和1991-2005三个时段,描述溃疡性结肠炎的流行病学、药物治疗及病变范围进展和结肠切除的长期风险。结果显示年年龄标化发病率从3.5/10万升至18.5/10万(P<.01),患病率从44/10万升至474/10万,10年结肠切除率13.5%(95%CI 11.1%-15.8%),1991-2005年诊断者风险低于1963-1975年(调整HR 0.61;95%CI 0.39-0.94;P=.02)。
要点
- 年年龄标化发病率从3.5/10万升至18.5/10万(P<.01),患病率从44/10万升至474/10万。
- 直肠炎和左半结肠炎10年病变范围进展风险分别为34.5%和18.5%(P<.01)。
- 10年结肠切除率13.5%(95%CI 11.1%-15.8%),1991-2005年诊断者低于1963-1975年(调整HR 0.61;95%CI 0.39-0.94;P=.02)。
核心结论
- 溃疡性结肠炎的发病率和患病率随时间增加,2010年观察到的患病率属于已报告的最高水平之一。
- 在最近数十年观察到结肠切除率下降,可能反映药物治疗的改善。
研究设计与样本
- 基于人群的队列研究,通过评估厄勒布鲁大学医院结肠炎门诊档案中的全部病历识别患者。
- 比较1963-1975年、1976-1990年和1991-2005年三个时段。
主要发现
- 年年龄标化发病率从3.5/10万升至18.5/10万(P<.01),患病率从1965年的44/10万升至2010年的474/10万。
- 诊断时广泛结肠炎男性比例高于女性(OR 1.55;95%CI 1.17-2.05;P<.01)。
- 直肠炎和左半结肠炎患者10年病变范围进展风险分别为34.5%和18.5%(P<.01)。
- 10年内5-氨基水杨酸使用率从1963-1975年的79%升至1976-1990年的92%(P<.01)。
- 硫嘌呤使用率从1976-1990年的7%升至1991-2005年的34%(P<.01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Whether the epidemiology of ulcerative colitis (UC) has changed during recent decades is partly unknown. AIM: To depict temporal trends in the epidemiology and medical treatment of UC as well as the long-term risk of progression in disease extent and colectomy, during 1963-2010. METHODS: Patients were identified by evaluation of all medical records in the archive of the Colitis Clinic, Örebro University Hospital. Comparisons were made between three time periods, 1963-1975, 1976-1990 and 1991-2005. RESULTS: The annual age-standardised incidence increased from 3.5 to 18.5 per 100 000 during the study period (P < .01). Correspondingly, the prevalence increased from 44 to 474 per 100 000 between 1965 and 2010. A higher proportion of males than females had extensive colitis at diagnosis (odds ratio: 1.55; 95% CI 1.17-2.05; P < .01). The risk for progression in disease extent was 34.5% and 18.5% at 10 years, for patients with proctitis and left-sided colitis, respectively (P < .01). The use of 5-aminosalicylates, within 10 years, rise from 79% to 92% between 1963-1975 and 1976-1990 (P < .01). Thiopurine use increased from 7% in 1976-1990 to 34% during 1991-2005 (P < .01). The colectomy rate at 10 years was 13.5% (95% CI 11.1%-15.8%), and the risk was lower among patients diagnosed in 1991-2005 compared to 1963-1975 (adjusted hazard ratio: 0.61; 95% CI 0.39-0.94; P = .02). CONCLUSION: The incidence and prevalence of UC increased over time, and the observed prevalence in 2010 is among the highest reported. In parallel, a decrease in colectomy rates was observed during the most recent decades, potentially reflecting improved medical treatment.
引用
- Eriksson C, Cao Y, Rundquist S, et al. Changes in medical management and colectomy rates: a population-based cohort study on the epidemiology and natural history of ulcerative colitis in Örebro, Sweden, 1963-2010. Aliment Pharmacol Ther. 2017. PMID: 28833287. doi:10.1111/apt.14268
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。